Spruce Biosciences (SPRB)

• Market cap: $59M
• 1 day: -4.86%
• 5 days: -20.37%
• 1 month: 1,087.64%
• 3 months: 968.88%
• 6 months: 968.88%
• Year to date: 232.96%
• 1 year: 161.03%
• 5 years: -92.81%
• 10 years: -91.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20